Zobrazeno 1 - 7
of 7
pro vyhledávání: '"John C Warwick"'
Publikováno v:
Journal of applied gerontology : the official journal of the Southern Gerontological Society. 40(8)
To identify patient risk factors for nonhome discharge (NHD) for home-dwelling older patients undergoing surgery, we performed a retrospective cohort study of patients aged ≥65 years undergoing elective surgery between 2014 and 2016 using the geria
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781475792119
Although monotherapy with available antiretroviral agents has proved useful in terms of delaying disease progression and improving the survival of persons with AIDS, the utility of these compounds as single agents is limited by several factors, inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6551929e49b524a0c2cae6b7cfeca83f
https://doi.org/10.1007/978-1-4757-9209-6_34
https://doi.org/10.1007/978-1-4757-9209-6_34
Publikováno v:
Journal of Applied Gerontology; Aug2021, Vol. 40 Issue 8, p856-864, 9p
Supplemental material, NHD_SuppTable3_052020_RU_June for Preoperative Risk Factors for Nonhome Discharge of Home-Dwelling Geriatric Patients Following Elective Surgery by John C. Warwick, Ethan Y. Brovman, Sascha S. Beutler and Richard D. Urman in Jo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f06b53f3fb5d5ed8e86f0e21ba1596
Autor:
Tommaso Nappo
The British Biographical Index, 3rd cumulated and enlarged ed., contains information on more than 420,000 individuals from Great Britain and Ireland from the beginnings until the end of the 20th century. 760 sources, published between 1601 and 2002,
Autor:
Ravi V. Durvasula, D. V. Subba Rao
Highly recommended by CHOICE, Oct 2018Extremophiles are nature's ultimate survivors, thriving in environments ranging from the frozen Antarctic to abyssal hot hydrothermal vents. Their lifeforms span bacteria to fishes, and are categorized as halophi
The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-